Integrated Multi‐Omics Analysis and Experimental Validation Identify <scp>UBE2Q2</scp> as a Candidate Molecule Target in Intervertebral Disc Degeneration

W.C.H. Cheng(Zhejiang Chinese Medical University), Jintao Hu(Zhejiang Chinese Medical University), Dong Wang(Zhejiang Chinese Medical University), Jianye Yang(First Affiliated Hospital of Chongqing Medical University), Chen M(Zhejiang Chinese Medical University), Fangfang Liu(Zhejiang Chinese Medical University), Hao Pan(Zhejiang Chinese Medical University), Weihui Qi(Zhejiang Chinese Medical University)
Journal of Cellular and Molecular Medicine
July 1, 2026
10.1111/jcmm.71292
Cited by 0

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Systemic clearance of <i>p16<sup>INK4a</sup></i>‐positive senescent cells mitigates age‐associated intervertebral disc degeneration
|Aging Cell|2019|170
Accelerated aging of intervertebral discs in a mouse model of progeria
|Journal of Orthopaedic Research®|2010|97
Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity
|Molecular Cancer|2019|84
Injectable hydrogel with nucleus pulposus-matched viscoelastic property prevents intervertebral disc degeneration
|Journal of Orthopaedic Translation|2022|66